The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer

NCT06861088 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thromboembolism
Metastatic Pancreatic Cancer
Locally Advanced Pancreatic Adenocarcinoma

Interventions

DRUG: Kinisoquin™
DRUG: Placebo

Sponsor

Quercis Pharma AG